Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €29.80 EUR
Change Today -0.14 / -0.47%
Volume 13.0K
KORI On Other Exchanges
Symbol
Exchange
EN Paris
Berlin
OTC US
As of 8:48 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for korian-medica (KORI)

Year over year, Korian-Medica has been able to grow revenues from €1.4B EUR to €2.2B EUR. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 28.82% to 26.87%. This was a driver that led to a bottom line growth from €28.6M EUR to €61.8M EUR.
View Income Statement In U.S. Dollar
Currency in
Millions of Euros
As of:Dec 31
2011
Reclassified
EUR
Dec 31
2012
Restated
EUR
Dec 31
2013
Restated
EUR
Dec 31
2014
EUR
4 Year
Trend
Revenues1,014.81,108.41,356.42,222.2
TOTAL REVENUES1,014.81,108.41,356.42,222.2
Cost of Goods Sold545.0602.2742.71,234.9
GROSS PROFIT469.8506.2613.7987.3
Selling General & Admin Expenses, Total308.6325.4391.0597.1
Depreciation & Amortization, Total37.144.761.798.7
Other Operating Expenses42.259.854.091.5
OTHER OPERATING EXPENSES, TOTAL387.8429.9506.7787.3
OPERATING INCOME82.076.3107.0200.0
Interest Expense-32.3-31.9-43.3-50.0
Interest and Investment Income0.40.10.00.1
NET INTEREST EXPENSE-31.9-31.8-43.3-49.9
Income (Loss) on Equity Investments-0.20.00.00.6
Other Non-Operating Income (Expenses)-0.8-1.8-1.8-5.3
EBT, EXCLUDING UNUSUAL ITEMS49.242.762.0145.4
Merger & Restructuring Charges-----14.8-19.4
Gain (Loss) on Sale of Investments-3.10.0-4.60.8
Gain (Loss) on Sale of Assets--10.012.62.2
Other Unusual Items, Total-------21.1
Other Unusual Items-------21.1
EBT, INCLUDING UNUSUAL ITEMS46.152.755.2107.8
Income Tax Expense20.526.823.842.8
Minority Interest in Earnings-3.1-2.6-2.8-3.3
Earnings from Continuing Operations25.625.931.465.1
EARNINGS FROM DISCOUNTINUED OPERATIONS-0.8------
NET INCOME21.723.328.661.8
NET INCOME TO COMMON INCLUDING EXTRA ITEMS21.723.328.661.8
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS22.423.328.661.8
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KORI:FP €29.80 EUR -0.14

KORI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Generale de Sante SA €14.58 EUR +0.33
Le Noble Age €20.30 EUR +0.08
Maternus-Kliniken AG €1.23 EUR -0.102
Orpea €63.17 EUR -0.38
RHOEN-KLINIKUM AG €24.25 EUR +0.072
View Industry Companies
 

Industry Analysis

KORI

Industry Average

Valuation KORI Industry Range
Price/Earnings 30.9x
Price/Sales 1.0x
Price/Book 1.1x
Price/Cash Flow 13.5x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KORIAN-MEDICA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.